Pardon my skepticism, but I have posted at least a dozen of
these announcements before.
If this one is legit and it is effective, there will be
serious doubts that it will be allowed to be put into use. Why do I say that? I say it because the fucking Pharmaceutical
companies would not be getting such a hefty profit from their HIV overpriced
drugs.
The billions of dollars of revenue that these drug
manufacturers get from HIV, cancer and other life-saving drugs is staggering.
If they don’t find a way of blocking and preventing it from going to market
they stand to lose all that obscene profit.
"Functional HIV Cure" Trial Advances
Sangamo BioSciences, Inc. (Nasdaq:
SGMO) announced today the initiation of two new Phase 2 clinical studies
(SB-728-1101 and SB-728-902, Cohort 5) in its program to develop a
"functional cure" for HIV/AIDS. Sangamo's ZFP Therapeutic® approach (SB-728-T)
generates T-cells that are resistant to HIV infection using its zinc finger
nuclease (ZFN) technology to permanently disrupt the DNA sequence encoding
CCR5, a co-receptor used by HIV to enter cells. The company expects to present
data from its SB-728-T HIV clinical trials at appropriate medical meetings in
2012.
Most interesting: "In addition
to safety, the study will evaluate the effect of escalating doses of Cytoxan on
SB-728-T engraftment, the effect of SB-728-T treatment on viral load following
HAART interruption." In other words (I think), they'll be looking at
whether patients can cease taking meds after the treatment.
Our thanks for bringing this post to us and for a great blog.
0 comments:
Post a Comment